MassDevice.com +5 | The top 5 medtech stories for May 31, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. J&J’s DePuy Synthes touts 4-year Attune knee revision data Johnson & Johnson subsidiary DePuy Synthes today touted 4-year data from a large registry study showing that its Attune knee implant had a lower revision rate than the overall rate for total knee replacement. The study examined data from 10,605 Attune implantations in Britain’s National Joint Registry for England, Wales, Northern Ireland & the Isle of Man, finding that the revision rate for Attune was 1.3% at 4 years, compared with the registry’s 1.9% average. Just 46 of the Attune knee procedures required revision, DePuy Synthes said. Read more 4. Medtronic launches opioid-induced respiratory depression study Medtronic said today that it’s starting a large study on the effect of pulse oximetry and capnography in opioid-induced respiratory depression, using its Capnostream device. The 1,650-patient Prodigy study aims to create a tool to score the risk of OIRD in patients being treated with opioids for pain, using Capnostream’s continuous pulse oximetry and capnography monitoring over 48 hours....
Source: Mass Device - Category: Medical Devices Authors: Tags: News Well Plus 5 Source Type: news